Program Directors |
Disclosure |
Teresa C. Chen, MD |
Alcon Laboratories, Inc.: S; Harvard Foundation Grant (Fidelity Charitable Fund): S |
Steven L. Mansberger, MD, MPH |
Abbvie: S, IQVIA: S, Nicox: C, ONL Therapeutics: C, Perfuse: C, THEA: C,S |
Program Planning Group |
Teresa C. Chen, MD |
Alcon Laboratories, Inc.: S, Harvard Foundation Grant (Fidelity Charitable Fund): S |
Steven L. Mansberger, MD, MPH |
Abbvie: S, IQVIA: S, Nicox: C, ONL Therapeutics: C, Perfuse: C, THEA: C,S |
Robert T. Chang, MD |
1800 Contacts: C, Alcon Laboratories, Inc.: C, Belkin laser: C, GENENTECH: C,S, Ocular Therapeutix: C, Optomed Corporation: C, Sight Sciences, Inc.: C, Smartlens: C, Verana Health: C, XP health: C |
Anna T. Do, MD |
Abbvie: L |
Christopher A. Girkin, MD, MSPH |
Amydis: SO, Heidelberg Engineering: C, S, IRIDEX: C, , Topcon Medical Systems Inc.: C, S |
Leon W Herndon Jr., MD |
Aerie Pharmaceuticals, Inc.: C, Alcon Laboratories, Inc.: C, Allergan, Inc: C, L, Elios: C, Equinox: C, GENENTECH: C, Glaukos Corporation: C, L, Graybug: C, New World Medical, Inc.: C, L, Ocular Therapeutix: C, S, Sight Sciences, Inc.: C |
Robert J. Noecker, MD, MBA |
Abbvie: C, L, Alcon Laboratories, Inc.: C, L, Bausch + Lomb: C, L, Beaver-Visitec International, Inc.: C, Glaukos Corporation: C, S, IRIDEX: C, L, New World Medical Inc.: L, C, Ocular Therapeutix: C, SO, Santen, Inc.: C, Sight Sciences, Inc.: C, SO, L, THEA: C |
Mary Qiu, MD |
NONE |
Manjool M. Shah, MD |
Alcon Laboratories, Inc.: C, Allergan/Abbvie: C, Elios: C, Glaukos Corporation: C, Katena Products, Inc.: C, Nova Eye Medical: C, ONL Therapeutics: C |
Ramya N. Swamy, MD, MPH |
NONE |
Richard Dwight Ten Hulzen, MD |
NONE |
Luis E. Vazquez, MD, PhD |
New World Medical, Inc.: L |